Concepedia

Min Zheng

MZ

Statistics

Publications

31

Citations

1.4K

H-Index

22

Active since

2009

Affiliations

Fujian Medical University(Current)

Beth Israel Deaconess Medical Center

Cancer Research Institute

Translational Therapeutics (United States)

First Affiliated Hospital of Fujian Medical University

Min Zheng is an author at Fujian Medical University specializing in medicine, oncology, and cancer cell signaling.

Publications per year

2009–2021

31

Publications

31

Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation

Qijing Wu, Wei Li, Jing Zhao et al. · Biomedicine & Pharmacotherapy · 2021 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway

Jichuang Wang, Nan Zhang, Qi Han et al. · Cancer Letters · 2018 · 109 citations

Medicine, Oncology, Pharmacology +16

Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy

Min Zheng, Lin‐Li Lv, Jie Ni et al. · PLoS ONE · 2011 · 101 citations · Full text

Medicine, Molecular Biology, Nephrology +17

The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation

Man‐Li Luo, Chang Gong, Chun-Hau Chen et al. · Cell Reports · 2015 · 89 citations · Full text

Medicine, Cell Biology, Oncology +15

A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways

Dayun Yang, Wensong Luo, Jichuang Wang et al. · Journal of Controlled Release · 2017 · 75 citations · Full text

Pharmacy, Oncology, Pharmacology +16

1–5 of 31